Jason Hoitt, Chief Patient Officer: Stoke Therapeutics STOK Sell · Filed 03/19

Trade details

Type: Insider sale
Amount: $33,820.42
Shares · price: 1,033 sh · $32.74 a share
Held after: 12,955 sh
Stock: Stoke Therapeutics STOK
Person: Jason HoittChief Patient Officer
Trade date: 26/03/17
Filed: 26/03/19
Days to filing: 2 days

Sold 7.4% of holdings

Share of holding sold: 7.4%

Stoke Therapeutics trades, last 26 weeks

What else happened in Stoke Therapeutics around then

Filed or reported within 30 days of the trade day · 02/15~04/16

Jason Hoitt's recent trades

Jason HoittChief Patient Officer
SellStoke Therapeutics
Sell
Stoke Therapeutics
STOK
$55.1K
1,762 sh
$55.1K
Filed 03/19
Traded 03/18
Jason HoittChief Patient Officer
SellStoke Therapeutics
Sell
Stoke Therapeutics
STOK
$25K
748 sh
$25K
Filed 03/19
Traded 03/17
Jason HoittChief Patient Officer
SellStoke Therapeutics
Sell
Stoke Therapeutics
STOK
$986
30 sh
$986
Filed 03/19
Traded 03/18
Jason HoittChief Patient Officer
SellStoke Therapeutics
Sell
Stoke Therapeutics
STOK
$4,419
139 sh
$4,419
Filed 03/19
Traded 03/18
Jason HoittChief Commercial Officer
SellProvention Bio
Sell
Provention Bio
PRVB
$45K
4,500 sh
$45K
Filed 23/02/14
Traded 23/02/10

Jason Hoitt, Chief Officer — sold $33.8K of Stoke Therapeutics STOK · 7.4% of holdings | Whalegun